{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T08:46:40Z","timestamp":1751532400028,"version":"3.32.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-024-12033-5","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T14:36:44Z","timestamp":1736174204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patterns of outpatient proton\u2012pump inhibitors use among older adults in a duplicative health system: comparing public and private prescribing"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7915-2896","authenticated-orcid":false,"given":"S\u00f3nia","family":"Romano","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8161-9264","authenticated-orcid":false,"given":"Ant\u00f3nio Teixeira","family":"Rodrigues","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5542-9993","authenticated-orcid":false,"given":"Carla","family":"Torre","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6634-9000","authenticated-orcid":false,"given":"Julian","family":"Perelman","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"12033_CR1","unstructured":"European Commission. Ageing Europe - Looking at the lives of older people in the EU. Eurostat 2020; 184."},{"key":"12033_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1475-6773.2005.00495.x","volume":"41","author":"SG Morgan","year":"2006","unstructured":"Morgan SG. Prescription drug expenditures and population demographics. Health Serv Res. 2006;41:411\u201328.","journal-title":"Health Serv Res"},{"key":"12033_CR3","doi-asserted-by":"crossref","unstructured":"al Hamid A, Ghaleb M, Aljadhey H, et al. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol 2014; 78: 202\u2013217.","DOI":"10.1111\/bcp.12293"},{"key":"12033_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF03319105","volume":"35","author":"C Chiatti","year":"2012","unstructured":"Chiatti C, Bustacchini S, Furneri G, et al. The Economic Burden of Inappropriate Drug Prescribing, Lack of Adherence and Compliance, Adverse Drug Events in Older People. Drug Saf. 2012;35:73\u201387.","journal-title":"Drug Saf"},{"key":"12033_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/gerona\/glw140","volume":"72","author":"E Wallace","year":"2017","unstructured":"Wallace E, Mcdowell R, Bennett K, et al. Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: A prospective cohort study. J Gerontol A Biol Sci Med Sci. 2017;72:271\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"12033_CR6","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1345\/aph.1M147","volume":"43","author":"K Johnell","year":"2009","unstructured":"Johnell K, Weitoft GR, Fastbom J. Sex differences in inappropriate drug use: a register-based study of over 600,000 older people. Ann Pharmacother. 2009;43:1233\u20138.","journal-title":"Ann Pharmacother"},{"key":"12033_CR7","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1111\/jgs.17194","volume":"69","author":"M Ukhanova","year":"2021","unstructured":"Ukhanova M, Markwardt S, Furuno JP, et al. Are there sex differences in potentially inappropriate prescribing in adults with multimorbidity? J Am Geriatr Soc. 2021;69:2163.","journal-title":"J Am Geriatr Soc"},{"key":"12033_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/ageing\/afw074","volume":"45","author":"SG Morgan","year":"2016","unstructured":"Morgan SG, Weymann D, Pratt B, et al. Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults. Age Ageing. 2016;45:535\u201342.","journal-title":"Age Ageing"},{"key":"12033_CR9","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2147\/PPA.S219346","volume":"13","author":"PA Sim\u00f5es","year":"2019","unstructured":"Sim\u00f5es PA, Santiago LM, Maur\u00edcio K, et al. Prevalence of potentially inappropriate medication in the older adult population within primary care in Portugal: A nationwide cross-sectional study. Patient Prefer Adherence. 2019;13:1569\u201376.","journal-title":"Patient Prefer Adherence"},{"key":"12033_CR10","doi-asserted-by":"crossref","unstructured":"Rocha V, Pl\u00e1cido AI, Rodrigues DA, et al. Geographic Variation in Top-10 Prescribed Medicines and Potentially Inappropriate Medication in Portugal: An Ecological Study of 2.2 Million Older Adults. International Journal of Environmental Research and Public Health 2022, Vol 19, Page 12938 2022; 19: 12938.","DOI":"10.3390\/ijerph191912938"},{"key":"12033_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00228-014-1651-8","volume":"70","author":"R Galvin","year":"2014","unstructured":"Galvin R, Moriarty F, Cousins G, et al. Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: Findings from the Irish LongituDinal Study on Ageing study (TILDA). Eur J Clin Pharmacol. 2014;70:599\u2013606.","journal-title":"Eur J Clin Pharmacol"},{"key":"12033_CR12","unstructured":"INFARMED. Inibidores da bomba de prot\u00f5es (IBP). Recomenda\u00e7\u00f5es Terap\u00eauticas 2017; 3\u20137."},{"key":"12033_CR13","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.3390\/ijerph19116896","volume":"19","author":"L Monteiro","year":"2022","unstructured":"Monteiro L, Monteiro-Soares M, Matos C, et al. Inappropriate Prescriptions in Older People\u2014Translation and Adaptation to Portuguese of the STOPP\/START Screening Tool. Int J Environ Res Public Health. 2022;19:6896.","journal-title":"Int J Environ Res Public Health"},{"key":"12033_CR14","first-page":"1","volume":"336","author":"I Forgacs","year":"2008","unstructured":"Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors Bmj. 2008;336:1\u20132.","journal-title":"Overprescribing proton pump inhibitors Bmj"},{"key":"12033_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5694\/mja18.00674","volume":"209","author":"P Bytzer","year":"2018","unstructured":"Bytzer P. Deprescribing proton pump inhibitors: why, when and how. Med J Aust. 2018;209:436\u20138.","journal-title":"Med J Aust"},{"key":"12033_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/2042098617715381","volume":"8","author":"ML Maes","year":"2017","unstructured":"Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf. 2017;8:273.","journal-title":"Ther Adv Drug Saf"},{"key":"12033_CR17","unstructured":"OECD. OECD Data. Pharmaceutical Spending, https:\/\/data.oecd.org\/healthres\/pharmaceutical-spending.htm#indicator-chart (2023, accessed 23 March 2024)."},{"key":"12033_CR18","doi-asserted-by":"publisher","unstructured":"OECD. Health at a Glance 2023 OECD indicators. Paris. Epub ahead of print 2023. https:\/\/doi.org\/10.1787\/7a7afb35-en.","DOI":"10.1787\/7a7afb35-en"},{"key":"12033_CR19","first-page":"1","volume":"19","author":"J de Almeida Sim\u00f5es","year":"2017","unstructured":"de Almeida Sim\u00f5es J, Augusto GF, Fronteira I, et al. Portugal: Health System Review. Health Syst Transit. 2017;19:1\u2013184.","journal-title":"Health Syst Transit"},{"key":"12033_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10198-020-01242-4","volume":"22","author":"AI Tavares","year":"2021","unstructured":"Tavares AI, Marques I. Multi-layer health insurance coverage, medical services use and health in a Universal National Health System, the case of Portugal. European Journal of Health Economics. 2021;22:141\u201353.","journal-title":"European Journal of Health Economics"},{"key":"12033_CR21","doi-asserted-by":"publisher","unstructured":"Portela M da CC, Fernandes AC. Medicines Compliance and Reimbursement Level in Portugal. Health Serv Res Manag Epidemiol; 2. Epub ahead of print 2015. https:\/\/doi.org\/10.1177\/2333392815601972.","DOI":"10.1177\/2333392815601972"},{"key":"12033_CR22","unstructured":"INE. Health Satellite Account 2019\u20132021Pe. Statistics Portugal 2022; 1\u201317."},{"key":"12033_CR23","unstructured":"OPSS. Observat\u00f3rio Portugu\u00eas dos Sistemas de Sa\u00fade (OPSS). Relat\u00f3rio de Primavera 2022. E Agora? (in Portuguese)."},{"key":"12033_CR24","unstructured":"Sociedade de consultores Augusto Mateus & Associados. Setor Privado da Sa\u00fade em Portugal. 2017."},{"key":"12033_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/fmch-2021-001325","volume":"9","author":"Z Xu","year":"2021","unstructured":"Xu Z, Liang X, Zhu Y, et al. Factors associated with potentially inappropriate prescriptions and barriers to medicines optimisation among older adults in primary care settings: a systematic review. Fam Med Community Health. 2021;9: e001325.","journal-title":"Fam Med Community Health"},{"key":"12033_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1590\/1516-3180.2020.0411.r1.18112020","volume":"139","author":"WW Amorim","year":"2021","unstructured":"Amorim WW, Passos LC, Gama RS, et al. Physician and patient-related factors associated with inappropriate prescribing to older patients within primary care: a cross-sectional study in Brazil. Sao Paulo Med J. 2021;139:107\u201316.","journal-title":"Sao Paulo Med J"},{"key":"12033_CR27","unstructured":"Order of medical doctors. Regulation No 724\/2019. Regulation of Standard Times for Medical Consultations. Republic Diary No 178\/2019, Series 2 of 2019\u201309\u201317 2019; 103\u2013118."},{"key":"12033_CR28","unstructured":"HMR Portugal. 2019 Pharmaceutical Market Overview | Portugal."},{"key":"12033_CR29","unstructured":"Portugal. Minist\u00e9rio da Sa\u00fade. Relat\u00f3rio Social do Minist\u00e9rio da Sa\u00fade e do Servi\u00e7o Nacional de Sa\u00fade. Lisboa, 2018."},{"key":"12033_CR30","unstructured":"ACSS. Operationalization of Contracting in Primary Health Care (in Portuguese). Biennium 2020 \/ 2021. 2020; 1\u201388."},{"key":"12033_CR31","unstructured":"Therapeutics Initiative. Comparative effectiveness of proton pump inhibitors. Therapeutics Letter Mach - April 2016; 1\u20132."},{"key":"12033_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1046\/j.1365-2036.2000.00788.x","volume":"14","author":"CAM Stedman","year":"2000","unstructured":"Stedman CAM, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther. 2000;14:963\u201378.","journal-title":"Aliment Pharmacol Ther"},{"key":"12033_CR33","unstructured":"Norma da Dire\u00e7\u00e3o Geral de Sa\u00fade no 036\/2011. Supress\u00e3o \u00c1cida: Utiliza\u00e7\u00e3o dos Inibidores da Bomba de Prot\u00f5es e das suas Alternativas Terap\u00eauticas. Dire\u00e7\u00e3o-Geral da Sa\u00fade 2011; 1\u201320."},{"key":"12033_CR34","unstructured":"WHO. International language for drug utilization research. WHO Collaborating Centre for Drug Statistics Methodology, https:\/\/www.whocc.no\/ (2023, accessed 23 March 2023)."},{"key":"12033_CR35","unstructured":"SPMS. System of Information and Monitoring of the Portuguese National Health System (SIM@SNS). Shared Services of the Ministry of Health (SPMS), https:\/\/bicsp.min-saude.pt\/pt\/investigacao\/Paginas\/medicamentoprescritor_publico.aspx?isdlg=1 (2023, accessed 30 January 2023)."},{"key":"12033_CR36","unstructured":"ACSS. Identity Card of Monitoring and Contractualization Indicators (070), https:\/\/sdm.min-saude.pt\/BI.aspx?id=70&clusters=S (2024, accessed 29 March 2024)."},{"key":"12033_CR37","unstructured":"INE. Annual estimate of resident population. Statistics Portugal (INE), www.ine.pt. (2023, accessed 25 July 2023)."},{"key":"12033_CR38","unstructured":"WHO. ATC-DDD Toolkit, https:\/\/www.who.int\/tools\/atc-ddd-toolkit (2024, accessed 3 December 2022)."},{"key":"12033_CR39","doi-asserted-by":"publisher","unstructured":"Nunes A. Vertical Integration in Healthcare and Patient Satisfaction: An Exploratory Analysis of Portuguese Reforms. Sustainability (Switzerland); 16. Epub ahead of print 1 February 2024. https:\/\/doi.org\/10.3390\/su16031078.","DOI":"10.3390\/su16031078"},{"issue":"71","key":"12033_CR40","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"2023","author":"AGS 2023 Criteria. The American Geriatrics Society","year":"2023","unstructured":"AGS 2023 Criteria. The American Geriatrics Society. updated the AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;2023(71):2052\u201381.","journal-title":"J Am Geriatr Soc"},{"key":"12033_CR41","doi-asserted-by":"publisher","unstructured":"Rodrigues DA, Herdeiro MT, Mateos-Campos R, et al. Magnitude and Determinants of Long-term Use of Proton Pump Inhibitors Among Portuguese Older Adults in Primary Health Care. Clin Ther. Epub ahead of print 2023. https:\/\/doi.org\/10.1016\/j.clinthera.2023.11.011.","DOI":"10.1016\/j.clinthera.2023.11.011"},{"key":"12033_CR42","doi-asserted-by":"publisher","unstructured":"Jussila E, Kotakorpi K, Verho J. Prescription Behavior of Physicians in the Public and Private Sector. SSRN Electronic Journal. Epub ahead of print 2022. https:\/\/doi.org\/10.2139\/SSRN.4324209.","DOI":"10.2139\/SSRN.4324209"},{"key":"12033_CR43","doi-asserted-by":"publisher","unstructured":"Nirwan JS, Hasan SS, Babar ZUD, et al. Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis. Sci Rep; 2;10(1):5814. Epub ahead of print 1 December 2020. https:\/\/doi.org\/10.1038\/s41598-020-62795-1.","DOI":"10.1038\/s41598-020-62795-1"},{"key":"12033_CR44","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1111\/j.1365-2036.2006.02924.x","volume":"23","author":"M Nocon","year":"2006","unstructured":"Nocon M, Keil T, Willich SN. Prevalence and sociodemographics of reflux symptoms in Germany \u2013 results from a national survey. Aliment Pharmacol Ther. 2006;23:1601\u20135.","journal-title":"Aliment Pharmacol Ther"},{"key":"12033_CR45","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1080\/07853890.2022.2074535","volume":"54","author":"D Zhang","year":"2022","unstructured":"Zhang D, Liu S, Li Z, et al. Global, regional and national burden of gastroesophageal reflux disease, 1990\u20132019: update from the GBD 2019 study. Ann Med. 2022;54:1372\u201384.","journal-title":"Ann Med"},{"key":"12033_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF03399261","volume":"144","author":"JC Salvado","year":"2008","unstructured":"Salvado JC. The Determinants of Health Care Utilization in Portugal: An Approach with Count Data Models. Swiss J Econ Stat. 2008;144:437\u201358.","journal-title":"Swiss J Econ Stat"},{"key":"12033_CR47","unstructured":"Ministry of Health. Order No. 224\/2015. Republic Diary No 144\/2015, Series 1 of 2015\u201307\u201327."},{"key":"12033_CR48","doi-asserted-by":"publisher","unstructured":"Rodrigues AT, Nunes JCF, Estrela M, et al. Comparing Hospital and Primary Care Physicians\u2019 Attitudes and Knowledge Regarding Antibiotic Prescribing: A Survey within the Centre Region of Portugal. Antibiotics; 10. Epub ahead of print 1 June 2021. https:\/\/doi.org\/10.3390\/ANTIBIOTICS10060629.","DOI":"10.3390\/ANTIBIOTICS10060629"},{"key":"12033_CR49","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.repce.2017.10.012","volume":"37","author":"D Pinto","year":"2018","unstructured":"Pinto D, Rodrigues AP, Nunes B. Initial therapeutic choices for hypertension in the Portuguese Sentinel Practice Network. Revista Portuguesa de Cardiologia (English Edition). 2018;37:657\u201363.","journal-title":"Revista Portuguesa de Cardiologia (English Edition)"},{"key":"12033_CR50","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/B978-0-444-53592-4.00006-2","volume":"2","author":"A Chandra","year":"2011","unstructured":"Chandra A, Cutler D, Song Z. Who Ordered That? The Economics of Treatment Choices in Medical Care. Handb Health Econ. 2011;2:397\u2013432.","journal-title":"Handb Health Econ"},{"key":"12033_CR51","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00228-023-03534-z","volume":"79","author":"LGT Shanika","year":"2023","unstructured":"Shanika LGT, Reynolds A, Pattison S, et al. Proton pump inhibitor use: systematic review of global trends and practices. Eur J Clin Pharmacol. 2023;79:1159.","journal-title":"Eur J Clin Pharmacol"},{"key":"12033_CR52","unstructured":"Antunes C, Aleem A, Curtis SA. Gastroesophageal Reflux Disease, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441938\/ (2023, accessed 1 February 2024)."},{"key":"12033_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/01.mcg.0000225631.07039.6d","volume":"41","author":"R Fass","year":"2007","unstructured":"Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol. 2007;41:131\u20137.","journal-title":"J Clin Gastroenterol"},{"key":"12033_CR54","doi-asserted-by":"publisher","unstructured":"Kim SY, Jung H-K, Lim J, et al. Gender Specific Differences in Prevalence and Risk Factors for Gastro-Esophageal Reflux Disease. J Korean Med Sci; 34. Epub ahead of print 6 June 2019. https:\/\/doi.org\/10.3346\/JKMS.2019.34.E158.","DOI":"10.3346\/JKMS.2019.34.E158"},{"key":"12033_CR55","doi-asserted-by":"publisher","first-page":"575","DOI":"10.5056\/jnm16138","volume":"22","author":"YS Kim","year":"2016","unstructured":"Kim YS, Kim N, Ha KG. Sex and Gender Differences in Gastroesophageal Reflux Disease. J Neurogastroenterol Motil. 2016;22:575\u201388.","journal-title":"J Neurogastroenterol Motil"},{"key":"12033_CR56","doi-asserted-by":"publisher","unstructured":"Quintal C, Louren\u00e7o \u00d3, Ferreira P. Utiliza\u00e7\u00e3o de cuidados de sa\u00fade pela popula\u00e7\u00e3o idosa portuguesa: uma an\u00e1lise por g\u00e9nero e classes latentes. Revista Portuguesa de Sa\u00fade P\u00fablica. Epub ahead of print 2011. https:\/\/doi.org\/10.1016\/j.rpsp.2012.02.001.","DOI":"10.1016\/j.rpsp.2012.02.001"},{"key":"12033_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-6-155","volume":"6","author":"\u00c1 Redondo-Sendino","year":"2006","unstructured":"Redondo-Sendino \u00c1, Guallar-Castill\u00f3n P, Banegas JR, et al. Gender differences in the utilization of health-care services among the older adult population of Spain. BMC Public Health. 2006;6:1\u20139.","journal-title":"BMC Public Health"},{"key":"12033_CR58","unstructured":"IHME. GBD Compare. Gastroesophageal reflux disease. Prevalent cases per 100,000. 2021. https:\/\/vizhub.healthdata.org\/gbd-compare\/#, https:\/\/vizhub.healthdata.org\/gbd-compare\/# (2024, accessed 13 February 2024)."},{"key":"12033_CR59","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.archger.2018.06.018","volume":"78","author":"L Mid\u00e3o","year":"2018","unstructured":"Mid\u00e3o L, Giardini A, Menditto E, et al. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213\u201320.","journal-title":"Arch Gerontol Geriatr"},{"key":"12033_CR60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s40273-021-01120-8","volume":"40","author":"S Romano","year":"2022","unstructured":"Romano S, Figueira D, Teixeira I, et al. Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations. Pharmacoeconomics. 2022;40:269\u201395.","journal-title":"Pharmacoeconomics"},{"key":"12033_CR61","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s11606-020-06089-2","volume":"35","author":"HE Bloomfield","year":"2020","unstructured":"Bloomfield HE, Greer N, Linsky AM, et al. Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis. J Gen Intern Med. 2020;35:3323\u201332.","journal-title":"J Gen Intern Med"},{"key":"12033_CR62","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/bcpt.13874","volume":"133","author":"A Pereira","year":"2023","unstructured":"Pereira A, Ribeiro O, Ver\u00edssimo M. Predictors of older patients\u2019 willingness to have medications deprescribed: A cross-sectional study. Basic Clin Pharmacol Toxicol. 2023;133:703\u201317.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"12033_CR63","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s11096-021-01328-w","volume":"43","author":"E Forest","year":"2021","unstructured":"Forest E, Ireland M, Yakandawala U, et al. Patient values and preferences on polypharmacy and deprescribing: a scoping review. Int J Clin Pharm. 2021;43:1461\u201399.","journal-title":"Int J Clin Pharm"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-12033-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-024-12033-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-12033-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T15:05:49Z","timestamp":1736175949000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-024-12033-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12033"],"URL":"https:\/\/doi.org\/10.1186\/s12913-024-12033-5","relation":{},"ISSN":["1472-6963"],"issn-type":[{"type":"electronic","value":"1472-6963"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain clinical studies or patient-level data. Data were derived from a publicly open access online platform of the Portuguese NHS; therefore, no access authorization was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}